NASDAQ:UTMD

Utah Medical Products Stock Forecast, Price & News

$83.34
+0.57 (+0.69 %)
(As of 06/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$83.00
$83.88
50-Day Range
$82.40
$89.29
52-Week Range
$77.22
$101.99
Volume7,830 shs
Average Volume10,598 shs
Market Capitalization$303.86 million
P/E Ratio28.54
Dividend Yield1.38%
Beta0.26
30 days | 90 days | 365 days | Advanced Chart
Receive UTMD News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.


Utah Medical Products logo

About Utah Medical Products

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.88 out of 5 stars

Medical Sector

1093rd out of 2,100 stocks

Surgical & Medical Instruments Industry

103rd out of 174 stocks

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Utah Medical Products (NASDAQ:UTMD) Frequently Asked Questions

What stocks does MarketBeat like better than Utah Medical Products?

Wall Street analysts have given Utah Medical Products a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Utah Medical Products wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Utah Medical Products' next earnings date?

Utah Medical Products is scheduled to release its next quarterly earnings announcement on Tuesday, July 27th 2021.
View our earnings forecast for Utah Medical Products
.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) issued its earnings results on Thursday, April, 22nd. The medical instruments supplier reported $0.83 earnings per share (EPS) for the quarter. The medical instruments supplier earned $10.96 million during the quarter. Utah Medical Products had a net margin of 25.29% and a trailing twelve-month return on equity of 10.65%.
View Utah Medical Products' earnings history
.

How has Utah Medical Products' stock been impacted by Coronavirus?

Utah Medical Products' stock was trading at $88.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, UTMD shares have decreased by 5.8% and is now trading at $83.34.
View which stocks have been most impacted by COVID-19
.

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products declared a quarterly dividend on Tuesday, May 11th. Stockholders of record on Tuesday, June 15th will be paid a dividend of $0.285 per share on Tuesday, July 6th. This represents a $1.14 annualized dividend and a yield of 1.37%. The ex-dividend date is Monday, June 14th.
View Utah Medical Products' dividend history
.

Is Utah Medical Products a good dividend stock?

Utah Medical Products pays an annual dividend of $1.14 per share and currently has a dividend yield of 1.38%.
View Utah Medical Products' dividend history.

Who are Utah Medical Products' key executives?

Utah Medical Products' management team includes the following people:
  • Mr. Kevin L. Cornwell, Chairman, CEO, Pres & Sec. (Age 74, Pay $327.34k)
  • Mr. Brian L. Koopman, Principal Financial Officer, Accounting Mang. & Controller (Age 51, Pay $123.5k)

What is Kevin L. Cornwell's approval rating as Utah Medical Products' CEO?

8 employees have rated Utah Medical Products CEO Kevin L. Cornwell on Glassdoor.com. Kevin L. Cornwell has an approval rating of 43% among Utah Medical Products' employees. This puts Kevin L. Cornwell in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Utah Medical Products' key competitors?

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), The Walt Disney (DIS), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR) and Axon Enterprise (AAXN).

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

Who are Utah Medical Products' major shareholders?

Utah Medical Products' stock is owned by a variety of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (7.68%), Renaissance Technologies LLC (6.77%), BlackRock Inc. (6.28%), Dimensional Fund Advisors LP (4.20%), Russell Investments Group Ltd. (3.42%) and JPMorgan Chase & Co. (1.77%). Company insiders that own Utah Medical Products stock include Barbara A Payne, Brian Koopman and Kevin L Cornwell.
View institutional ownership trends for Utah Medical Products
.

Which institutional investors are selling Utah Medical Products stock?

UTMD stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Dimensional Fund Advisors LP, Northern Trust Corp, Millennium Management LLC, Clean Yield Group, Morgan Stanley, Loomis Sayles & Co. L P, and JPMorgan Chase & Co..
View insider buying and selling activity for Utah Medical Products
or view top insider-selling stocks.

Which institutional investors are buying Utah Medical Products stock?

UTMD stock was acquired by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Goldman Sachs Group Inc., Mercer Global Advisors Inc. ADV, BlackRock Inc., Brandes Investment Partners LP, Squarepoint Ops LLC, Envestnet Asset Management Inc., and The Manufacturers Life Insurance Company.
View insider buying and selling activity for Utah Medical Products
or or view top insider-buying stocks.

How do I buy shares of Utah Medical Products?

Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $83.34.

How much money does Utah Medical Products make?

Utah Medical Products has a market capitalization of $303.86 million and generates $42.18 million in revenue each year.

How many employees does Utah Medical Products have?

Utah Medical Products employs 181 workers across the globe.

What is Utah Medical Products' official website?

The official website for Utah Medical Products is www.utahmed.com.

Where are Utah Medical Products' headquarters?

Utah Medical Products is headquartered at 7043 South 300 West, Midvale UT, 84047.

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at 801-566-1200.


This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.